Macrogenics inc

Major-Pharmaceuticals

MGNX


9704 Medical Center Drive
Rockville , MD 20850

Executive/
Director

Price

  • Last Close
  • $ 3.48
    $ +0.02 0.58 %
    Aug 29, 2024
  • 52-Week High/Low
  • $21.47 - $3.22
  • YTD
  • -63.9%

  • Trading Volume
  • 13,074
  • Market Cap Full
  • $ 215.9M
  • Shares Outstanding
  • 62M
    Nov 3, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 -10.6% -39.5% -9% 32.4% 41.6% -5% 39.3% -44.9% 6.9% 53%
Q2 21% 44% -5.9% -9.8% -9.4% 4% -15.7% -66.7% -25.4% -5.1%
Q3 -43.6% 10.8% 5.5% 2.3% -25.6% 8% -22% 17.3% -12.9% -
Q4 44.6% -31.7% 1.5% -39.8% -16.9% -9.3% -23.4% 93.9% 114.7% -
J F M A M J J A S O N D
2024 48.7% 25.5% -18% -9.6% - - - - - - - -
2023 -14% 5.6% 17.7% -3.9% -32.2% 14.6% -10.8% -2.3% - 12% 57.3% 17.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    28%-12%-34%-7%-33%-17%117%-30%-58%43%-64%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.58 0.88 1.08 -1.34 -0.99 -0.91 -0.9 -1.08 -0.61
Q2 0.71 1.12 1.14 -1.03 -0.65 -0.94 -0.66 -0.67 0.92
Q3 0.46 0.97 1.28 -0.81 -0.91 -0.66 -0.86 -0.4 0.28
Q4 0.89 1 2.80 -1.01 -0.61 0.04 -0.95 0.20 -
A 2.6 4 6.3 -4.2 -3.2 -2.5 -3.4 -2 0.59

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 48.8 49 56.3 61.3 61.8
Jun 42.2 48.8 49.1 60 61.3 61.8
Sep 42.2 48.9 54.1 61.1 61.5 61.9
Dec 42.3 48.9 56.2 61.3 61.5 62

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 7 0.8 - - -
Fixed Asset Turnover 4.9 1.4 1.6 0.9 1
Total Asset Turnover 0.5 0.2 0.3 0.2 0.2
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 121 203 131 7.1 -
Equity multiplier 0.2 0.2 0.2 0.3 0.3